Načítá se...
Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer
BACKGROUND: Ovarian cancer is the eighth most common cancer in women and it is usually diagnosed at an advanced stage. The majority of ovarian tumours are epithelial in origin. Women with relapsed epithelial ovarian cancer (EOC) often have a reduced performance status with a limited life expectancy,...
Uloženo v:
| Vydáno v: | Cochrane Database Syst Rev |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Ltd
2013
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6457816/ https://ncbi.nlm.nih.gov/pubmed/23835762 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD006910.pub2 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|